Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-013142
Filing Date
2015-02-23
Accepted
2015-02-23 21:39:59
Documents
1
Period of Report
2015-02-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3090
  Complete submission text file 0001104659-15-013142.txt   4475
Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address
MEGLASSON MARTIN (Reporting) CIK: 0001280564 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 15641673

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations